Radiation Therapy Plus Irinotecan in Treating Patients With Colon Cancer

Part of paid clinical trials in Charleston, South Carolina.

Sponsor
Medical University of South Carolina
Study ID
NCT00003344
Phase
PHASE1/PHASE2
Status
Completed

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - 120 Years
Healthy Volunteers
Not accepted

Interventions

Study Details

RATIONALE: Radiation therapy uses high energy x-rays to damage tumor cells. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells. PURPOSE: Phase I/II trial to study the effectiveness of radiation therapy plus irinotecan in treating patients with colon cancer that is recurrent or that cannot be removed surgically.

Key Dates

Start date
Aug 31, 1998
Status verified
May 2018
Primary completion
Jan 31, 2000
Completion
Jan 31, 2000

Study Design

Enrollment
49 participants
Primary purpose
TREATMENT

Locations (1)

FacilityCityStateZIPSite coordinators
Medical University of South CarolinaCharlestonSouth Carolina29425-0721-

Find similar trials in Charleston, SC

By condition
Colorectal cancer
By specialty
OncologyGI oncology
By research site
Medical University of South Carolina· Charleston, SC

Related Studies